Add BrightSurf on Google Email

Science News Archive 2025 - Page 72


Page 72 of 574

Personalized risk messages fail to boost colorectal cancer screening participation

A randomized controlled trial found that personalized risk messages failed to increase colorectal cancer screening participation. Despite the lack of improvement, researchers emphasize the importance of continued research and potential improvements for uptake, effectiveness, and efficiency of CRC screening.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateSep 1, 2025

AI co-pilot boosts noninvasive brain-computer interface by interpreting user intent

Researchers at UCLA have developed a wearable noninvasive brain-computer interface system that utilizes AI to interpret user intent, allowing participants to complete tasks significantly faster with assistance. The system demonstrates promising results for technology to assist individuals with limited physical capabilities.

SourceUniversity of California - Los Angeles·JournalNature Machine Intelligence·TypeExperimental study·DateSep 1, 2025

For the first time in 40 Years, Panama’s deep and cold ocean waters failed to emerge, possibly affecting fisheries and coral health

Scientists from the Smithsonian Tropical Research Institute recorded that Panama's Pacific upwelling did not occur in 2025, leading to diminished temperature drops and productivity spikes. The researchers attribute this event to a significant reduction in wind patterns, highlighting the vulnerability of tropical upwelling systems.

SourceSmithsonian Tropical Research Institute·JournalProceedings of the National Academy of Sciences·DateSep 1, 2025

CRISPR’s efficiency triples with DNA-wrapped nanoparticles

Researchers at Northwestern University have developed a new CRISPR delivery system that triples efficiency using DNA-wrapped nanoparticles, improving safety and effectiveness. The new system, called LNP-SNAs, targets specific cells and tissues, reducing toxicity and boosting gene-editing efficiency by threefold.

SourceNorthwestern University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateSep 1, 2025

Solar Orbiter traces superfast electrons back to Sun

The European Space Agency-led Solar Orbiter mission has split energetic particles into two groups, tracing them back to distinct solar outbursts. Researchers found that one type of particle is connected to intense solar flares and the other to larger coronal mass ejections.

SourceEuropean Space Agency·JournalAstronomy and Astrophysics·TypeObservational study·DateSep 1, 2025

Study Reveals Details of Overactive Immune System in Patients with Chronic Fatigue Syndrome (ME/CFS)

Researchers analyzed blood samples from 56 ME/CFS patients and 52 healthy controls, revealing disruptions in metabolic processes and immune dysregulation. The study suggests specific intracellular pathways correlate with symptoms, leading to potential biomarkers for targeted interventions.

SourceColumbia University's Mailman School of Public Health·Journalnpj Metabolic Health and Disease·TypeObservational study·DateSep 1, 2025

GaN-based electron beam technology from Nagoya University startup poised to overcome critical semiconductor manufacturing challenges at KIOXIA

A new GaN-based e-beam technology has been developed through joint research between Photo electron Soul and Nagoya University, enabling non-contact electrical inspection and metrology during semiconductor manufacturing. The technology is expected to improve yield and defect detection, leading to increased efficiency in the industry.

Developing solid oxide electrolysis cells for CO2 conversion: A critical power-to-X approach

Researchers analyzed high-temperature solid oxide electrolysis cells (SOECs) for CO₂ conversion, categorizing mechanisms into oxygen ion-conducting (O-SOECs) and proton-conducting (H-SOECs). They identified key global manufacturers and market trends, outlining pathways for efficient CO₂ conversion and energy storage.

SourceHigher Education Press·JournalFrontiers in Energy·TypeExperimental study·DateAug 31, 2025

Metformin changes blood metal levels in humans

A Kobe University study found that metformin reduces copper and iron levels and increases zinc levels in patients with type 2 diabetes. This suggests a possible mechanism for the drug's beneficial effects beyond lowering blood sugar levels.

SourceKobe University·JournalBMJ Open Diabetes Research & Care·TypeExperimental study·DateAug 31, 2025

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

A study published in JAMA found that fractional flow reserve-guided complete revascularization during index procedure resulted in a significant reduction in composite of all-cause death, nonfatal myocardial infarction, any revascularization, and stroke at 1 year. Reduced repeat revascularization was the main driver of this benefit.

SourceJAMA Network·JournalJAMA·DateAug 31, 2025

Smart phenotyping robot transforms crop monitoring for food security

A new phenotyping robot developed by Nanjing Agricultural University's team enables accurate and reliable plant tracking in various environments. The robot integrates multisensor fusion algorithms and advanced navigation systems to collect high-throughput phenotypic data, bridging the gap between genomics and observable traits.

SourceNanjing Agricultural University The Academy of Science·JournalPlant Phenomics·TypeExperimental study·DateAug 30, 2025

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

A major new analysis from the REBOOT trial reveals that women treated with beta-blockers after a heart attack had a higher risk of death, reinfarction, or hospitalization for heart failure. The study also found that women presenting with infarction had a worse cardiovascular profile and a significantly worse prognosis than men.

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

A new study published in The New England Journal of Medicine and the European Heart Journal finds that beta blockers, commonly prescribed after a heart attack, provide no clinical benefit for patients with preserved heart function. Women treated with beta blockers had a higher risk of death, heart attack, or hospitalization for heart f...

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateAug 30, 2025

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

A new clinical trial has found that beta-blockers, commonly prescribed for cardiac conditions, offer no clinical benefit for patients who have had an uncomplicated myocardial infarction. The REBOOT trial enrolled 8,505 patients and showed no significant differences between those receiving or not receiving beta-blockers in rates of deat...

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalNew England Journal of Medicine·TypeMeta-analysis·DateAug 30, 2025

Promising new drug for people with stubborn high blood pressure

A Phase III clinical trial has shown that baxdrostat significantly lowers blood pressure in people whose levels remain dangerously high despite taking multiple existing medicines. The study found that nearly 4 in 10 patients achieved healthy blood pressure levels, compared to fewer than 2 in 10 on placebo.

SourceUniversity College London·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateAug 30, 2025

SEOULTECH researchers develop revolutionary 3D-printed smart materials create high-performance pressure sensors for wearables

The Seoul National University of Science and Technology has developed a novel 3D AMM-based tactile sensing platform that offers high-performance pressure sensing. The technology leverages auxetic metamaterials to enhance sensitivity, stability, and scalability.

SourceSeoul National University of Science & Technology·JournalAdvanced Functional Materials·TypeExperimental study·DateAug 29, 2025

All DRII-ed up: How do plants recover after drought?

Researchers discovered that plants rapidly activate a coordinated immune response during drought recovery, prioritizing immunity over growth. This finding highlights the importance of studying the post-drought period and points to new strategies for engineering crops that can rebound more effectively after environmental stress.

SourceSalk Institute·JournalNature Communications·DateAug 29, 2025